Navigation Links
Nobel Laureate to Join Grove Instruments Board of Directors
Date:12/5/2011

WORCESTER, Mass., Dec. 5, 2011 /PRNewswire/ -- Grove Instruments, Inc., a medical device company based in Worcester, MA, developing the world's first noninvasive glucometer today announced that Craig Mello, Ph.D. is joining the Board of Directors.  Dr. Mello is a Howard Hughes Medical Institute Investigator and the Blais University Chair of Molecular Medicine and Co-Director of the RNA Therapeutics Institute at the University of Massachusetts School of Medicine.  Dr. Mello's pioneering research on RNA inhibition (RNAi), in collaboration with Dr. Andrew Fire, has been recognized with numerous prestigious awards culminating with the 2006 Nobel Prize in Physiology or Medicine. "We are building a world class medical technology company and the addition of Dr. Mello to our Board is another step in our continuing quest for excellence at every level," said Arthur Combs, CEO of Grove.

Dr. Mello's renown in the scientific community is equaled only by his dedication to the care of people with diabetes.  His passion and commitment for diabetes care emanate from a deeply personal experience raising a child with type 1 diabetes.  "Experiencing the 24-hour-a-day every day nature of this disease, really makes you appreciate the tremendous potential benefit of Grove's technology," says Mello.  After 2 years as an Advisor to the Company Dr. Mello decided, "I wanted more involvement – an opportunity to make a bigger impact on the success of the Company and its technology."

"Having a man of science with Dr. Mello's credentials and gravitas is just fantastic for the Company," noted Dr. Paul Lock, career diabetologist and longest seated Board member.  Dr. Robert Peura, Grove Co-founder and father of two children with type 1 diabetes, said, "This is just terrific! I know how powerful it will be to have Craig join us – I know he truly understands the needs of children with diabetes, and how Grove can help."

"This has been a landmark year for Grove – technologically and organizationally.  Having Dr. Mello join us is the perfect culmination to a great year, and a huge head start on the future," said Combs of Grove's Board being enhanced by the Nobel Laureate.

About Grove Instruments

Grove Instruments, Inc. is a privately held pre-market medical device company developing the world's first noninvasive glucometer with the potential to exceed the ISO standard for blood glucose meters.  Grove's patented technology is based on the seminal concept of the Optical Bridge and is unique among all NIR spectroscopic approaches to noninvasive blood glucose determination.  The Company has been recognized for its innovation, technology development and clinical results on 10 separate occasions by the NIH NIDDK with funded SBIR Grants. In 2011, Grove was also recognized by the Massachusetts Life Sciences Center with an Accelerator Award – one of only 4 recipients out of all Boston-area life sciences companies applying in that round.  For more information see www.groveinstruments.com.


'/>"/>
SOURCE Grove Instruments, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elsevier Honors the 2011 Nobel Laureates
2. Argos Therapeutics Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System
3. Live Coverage of 2011 Nobel Prize Announcements and Exclusive Content on Nobelprize.org
4. Elsevier Celebrates Nine 2010 Nobel Laureates and Honors Achievements With Freely Available Prize-Winning Research
5. Thomson Reuters Predicts Nobel Laureates
6. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
7. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
8. Nobel Prize-Winning Discovery
9. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
10. Laureate Biopharma to Produce Biosimilar Product for Leading Generics Company
11. Laureates Electronic Submission Gateway Approved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):